SCHEMBL4240787

SCHEMBL4240787

CC(C)(C)OC(=O)N1CCc2cc(NC3CCNCC3)ccc21

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.46
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
MAPT P10636 1/20 0.45
MAPK1 P28482 1/20 0.45
HTT P42858 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
GPR119 Q8TDV5 7/20 0.44
KDM1A O60341 2/20 0.43
KDM1B Q8NB78 2/20 0.43
MAOB P27338 1/20 0.43
DHODH Q02127 1/20 0.43
BRD4 O60885 2/20 0.41
ATAD2 Q6PL18 1/20 0.41
PDK2 Q15119 1/20 0.40
DDB1 Q16531 1/20 0.40
CRBN Q96SW2 1/20 0.40
TRIM24 O15164 2/20 0.40
BRPF1 P55201 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31013842 0.83 GPR119 (0.43) ALDH1A1NPC1RAB9AMAPTMAPK1
SCHEMBL4247895 0.79 PDK2 (0.52) ALDH1A1NPC1RAB9AMAPTMAPK1
SCHEMBL12464373 0.78 ALDH1A1 (0.53) ALDH1A1NPC1RAB9AMAPTGPR119
SCHEMBL8257530 0.77 HTR6 (0.46) GPR119DHODHBRD4
SCHEMBL8269763 0.75 GPR119 (0.47) GPR119DHODHBRD4
SCHEMBL28429987 0.75 GPR119 (0.50) GPR119DHODHBRD4TRIM24BRPF1
SCHEMBL30681488 0.75 GPR119 (0.50) GPR119DHODHBRD4TRIM24BRPF1
SCHEMBL8200750 0.74 NOTUM (0.64) ALDH1A1GPR119DHODHBRD4
SCHEMBL3899182 0.74 ESR2 (0.61) GPR119DHODHBRD4PDK2
SCHEMBL1051317 0.74 RAB9A (0.60) ALDH1A1NPC1RAB9AMAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7491735-B2 Chemokine receptor binding compounds GENZYME CORPORATION (US) 2009-02-17 US disclosed
EP-1708703-A4 CHEMOKINE RECEPTOR BINDING COMPOUNDS ANORMED INC (CA) 2008-04-09 EP disclosed
EP-1708703-A2 CHEMOKINE RECEPTOR BINDING COMPOUNDS ANORMED INC. (CA) 2006-10-11 EP disclosed
US-20050277670-A1 Chemokine receptor binding compounds ANORMED INC. 2005-12-15 US disclosed
WO-2005059107-A2 CHEMOKINE RECEPTOR BINDING COMPOUNDS ANORMED INC. (CA) 2005-06-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050277670-A1 Chemokine receptor binding compounds CCR5, CXCR3, CCL5 ALDH1A1 3358/4885NPC1 542/4885RAB9A 2043/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.